# OnCo record extremity-soft-tissue-sarcoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/extremity-soft-tissue-sarcoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "extremity-soft-tissue-sarcoma" ;
  schema:name "Soft tissue sarcoma of the extremity (localised and advanced)"@en ;
  schema:alternateName "Limb sarcoma"@en, "Extremity STS"@en, "Localised soft tissue sarcoma"@en, "Advanced soft tissue sarcoma"@en ;
  schema:description "Most soft tissue sarcomas arise in an arm or leg. Limb-saving surgery with radiotherapy cures most localised tumours and is as safe as amputation. For spread disease doxorubicin is the backbone: adding ifosfamide shrinks more tumours without lengthening life, and in leiomyosarcoma adding trabectedin doubles the time the disease stays controlled."@en ;
  schema:url <https://onco.cc/cancers/extremity-soft-tissue-sarcoma/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Soft-tissue_sarcoma> ;
  schema:citation <https://en.wikipedia.org/wiki/Soft-tissue_sarcoma> ;
  onco:tag "subtype-page" ;
  onco:related <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/leiomyosarcoma/>, <https://onco.cc/cancers/uterine-sarcoma/>, <https://onco.cc/cancers/liposarcoma/>, <https://onco.cc/cancers/synovial-sarcoma/>, <https://onco.cc/cancers/undifferentiated-pleomorphic-sarcoma/> ;
  onco:pipeline <https://onco.cc/trials/lms-04/>, <https://onco.cc/trials/isg-sts-1001/>, <https://onco.cc/drugs/trabectedin/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:standardOfCare <https://onco.cc/technologies/limb-salvage-surgery/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/terms/fnclcc-grade/>, <https://onco.cc/trials/isg-sts-1001/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/technologies/hyperthermia/>, <https://onco.cc/technologies/isolated-limb-perfusion/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/trials/eortc-62012/>, <https://onco.cc/drugs/trabectedin/>, <https://onco.cc/trials/lms-04/>, <https://onco.cc/trials/announce/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/pazopanib/>, <https://onco.cc/drugs/trabectedin/>, <https://onco.cc/drugs/eribulin/>, <https://onco.cc/technologies/sbrt/>, <https://onco.cc/terms/sarcoma-histotype-tailoring/> .